体外诊断成分股数据 申万3级
851534.SI (39)
数据更新时间：2025-12-17
"-"表示无或者负数
| 序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值（亿元）
|
归母净利润同比增长(09-30)
|
归母净利润同比增长(06-30)
|
营业收入同比增长(09-30)
|
营业收入同比增长(06-30)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 002932.SZ | 明德生物 | 2018-07-17 | — | — | 体外诊断 | 17.69 | 55.2 | 579.6 | 0.74 | 6.4% | 41.13 | -83.30% | -80.82% | 0.53% | -9.71% |
| 2 | 688389.SH | 普门科技 | 2023-09-25 | — | — | 体外诊断 | 13.17 | 16.34 | 22.48 | 2.69 | — | 56.43 | -36.66% | -29.27% | -10.96% | -14.08% |
| 3 | 002086.SZ | 东方海洋 | 2024-01-02 | — | — | 体外诊断 | 2.38 | — | — | 3.52 | — | 46.62 | -51.43% | -71.23% | -0.78% | 0.34% |
| 4 | 300439.SZ | 美康生物 | 2015-04-29 | — | — | 体外诊断 | 9.84 | 14.66 | 40.16 | 1.28 | 1.37% | 37.82 | -73.02% | -68.15% | -19.27% | -22.43% |
| 5 | 002030.SZ | 达安基因 | 2004-08-16 | — | — | 体外诊断 | 6.07 | — | — | 1.1 | — | 85.19 | 71.85% | 54.37% | -14.81% | -15.44% |
| 6 | 688253.SH | 英诺特 | 2023-09-25 | — | — | 体外诊断 | 31.46 | 17.46 | 32.3 | 2.12 | — | 43.10 | -46.37% | -39.36% | -36.56% | -34.35% |
| 7 | 300642.SZ | 透景生命 | 2017-04-28 | — | — | 体外诊断 | 18.3 | 86.14 | 186.89 | 2.02 | 0.81% | 29.75 | -76.33% | -58.41% | -19.73% | -26.25% |
| 8 | 600645.SH | 中源协和 | 1999-12-30 | — | — | 体外诊断 | 25.81 | 120.35 | 161.58 | 3.25 | — | 120.78 | -19.18% | -32.18% | -9.41% | -10.71% |
| 9 | 688606.SH | 奥泰生物 | 2023-09-25 | — | — | 体外诊断 | 63.33 | 16.6 | 17.03 | 1.31 | — | 50.21 | -3.91% | 6.57% | 2.44% | 8.41% |
| 10 | 688217.SH | 睿昂基因 | 2023-09-25 | — | — | 体外诊断 | 25.1 | — | — | 1.57 | — | 14.02 | -198.14% | -61.46% | -26.64% | -22.29% |
| 11 | 688068.SH | 热景生物 | 2023-09-25 | — | — | 体外诊断 | 170.4 | — | — | 5.39 | — | 157.97 | -168.12% | -93.24% | -19.80% | -18.04% |
| 12 | 300942.SZ | 易瑞生物 | 2021-02-23 | — | — | 体外诊断 | 9.37 | 221.74 | 121.48 | 4.49 | 0.18% | 37.95 | 362.49% | 250.02% | 17.45% | 5.44% |
| 13 | 002022.SZ | 科华生物 | 2004-07-28 | — | — | 体外诊断 | 5.97 | — | — | 0.99 | — | 30.71 | -90.38% | -154.37% | -11.77% | -12.65% |
| 14 | 688298.SH | 东方生物 | 2023-09-25 | — | — | 体外诊断 | 23.98 | — | — | 0.76 | — | 48.34 | 18.89% | -7.58% | 2.16% | -3.62% |
| 15 | 688399.SH | 硕世生物 | 2023-09-25 | — | — | 体外诊断 | 66.41 | — | — | 1.88 | — | 55.70 | -88.38% | -86.35% | -3.95% | -1.05% |
| 16 | 688575.SH | 亚辉龙 | 2023-09-25 | — | — | 体外诊断 | 14.22 | 26.95 | 56.69 | 3.0 | — | 81.25 | -72.36% | -84.82% | -7.69% | -15.79% |
| 17 | 688393.SH | 安必平 | 2023-09-25 | — | — | 体外诊断 | 22.13 | 97.25 | — | 1.69 | — | 20.71 | -136.34% | -176.38% | -28.29% | -30.11% |
| 18 | 688468.SH | 科美诊断 | 2023-09-25 | — | — | 体外诊断 | 7.32 | 23.11 | 51.98 | 2.08 | — | 29.36 | -62.94% | -68.24% | -24.13% | -27.03% |
| 19 | 688338.SH | 赛科希德 | 2023-09-25 | — | — | 体外诊断 | 25.51 | 23.96 | 28.84 | 1.63 | — | 27.08 | -22.83% | -23.47% | -13.62% | -12.62% |
| 20 | 688067.SH | 爱威科技 | 2023-09-25 | — | — | 体外诊断 | 23.78 | 70.79 | 60.0 | 3.14 | — | 16.17 | 16.35% | 21.16% | 11.63% | 12.70% |
| 21 | 688317.SH | 之江生物 | 2023-09-25 | — | — | 体外诊断 | 20.12 | — | — | 1.14 | — | 38.66 | -125.82% | -137.88% | -34.27% | -36.91% |
| 22 | 300463.SZ | 迈克生物 | 2015-06-04 | — | — | 体外诊断 | 11.31 | 53.93 | — | 1.08 | 0.93% | 68.39 | -86.81% | -83.12% | -17.44% | -15.94% |
| 23 | 688426.SH | 康为世纪 | 2024-07-31 | — | — | 体外诊断 | 24.42 | — | — | 1.98 | — | 27.47 | 20.37% | -11.70% | 42.01% | 29.74% |
| 24 | 688193.SH | 仁度生物 | 2023-09-25 | — | — | 体外诊断 | 44.18 | — | — | 1.94 | — | 17.70 | 50.15% | -52.94% | -8.79% | -6.27% |
| 25 | 300832.SZ | 新产业 | 2020-05-19 | — | — | 体外诊断 | 60.27 | 25.9 | 28.71 | 5.42 | 2.16% | 473.55 | -12.92% | -14.62% | 0.39% | -1.18% |
| 26 | 300685.SZ | 艾德生物 | 2017-08-09 | — | — | 体外诊断 | 20.49 | 31.48 | 27.65 | 4.1 | 1.46% | 80.23 | 15.50% | 31.41% | 2.08% | 6.69% |
| 27 | 300396.SZ | 迪瑞医疗 | 2014-09-17 | — | — | 体外诊断 | 12.83 | 24.65 | — | 1.85 | 2.03% | 34.99 | -145.31% | -117.13% | -60.12% | -60.07% |
| 28 | 300406.SZ | 九强生物 | 2014-11-06 | — | — | 体外诊断 | 13.23 | 14.56 | 17.97 | 2.09 | 6.77% | 77.57 | -27.03% | -30.01% | -18.24% | -18.67% |
| 29 | 603387.SH | 基蛋生物 | 2017-07-24 | — | — | 体外诊断 | 8.08 | 18.32 | 19.63 | 1.52 | 2.23% | 40.98 | -8.48% | -25.88% | -13.88% | -17.00% |
| 30 | 002432.SZ | 九安医疗 | 2022-08-01 | — | — | 体外诊断 | 41.18 | 11.47 | 10.13 | 0.86 | 0.45% | 191.45 | 16.11% | 52.91% | -48.89% | -43.35% |
| 31 | 300289.SZ | 利德曼 | 2012-02-23 | — | — | 体外诊断 | 6.91 | — | — | 2.27 | — | 37.59 | -765.83% | -800.43% | -10.49% | -14.80% |
| 32 | 603658.SH | 安图生物 | 2016-09-08 | — | — | 体外诊断 | 35.99 | 17.22 | 18.73 | 2.35 | 3.5% | 205.66 | -10.11% | -7.83% | -7.48% | -6.65% |
| 33 | 300482.SZ | 万孚生物 | 2015-07-07 | — | — | 体外诊断 | 19.9 | 16.59 | 35.9 | 1.73 | 2.07% | 93.15 | -69.32% | -46.82% | -22.52% | -20.92% |
| 34 | 688289.SH | 圣湘生物 | 2023-09-25 | — | — | 体外诊断 | 18.67 | 39.25 | 39.84 | 1.52 | — | 108.17 | -2.10% | 3.84% | 20.49% | 21.15% |
| 35 | 300639.SZ | 凯普生物 | 2017-04-19 | — | — | 体外诊断 | 5.44 | — | — | 0.92 | — | 35.17 | 51.25% | -16.46% | -20.38% | -22.96% |
| 36 | 600807.SH | 济高发展 | 2024-07-31 | — | — | 体外诊断 | 3.13 | — | — | 63.11 | — | 27.69 | -78.54% | -57.51% | -17.59% | -23.36% |
| 37 | 688656.SH | 浩欧博 | 2023-09-25 | — | — | 体外诊断 | 196.5 | 338.93 | 342.4 | 15.05 | — | 124.74 | -1.41% | -39.10% | -4.84% | -6.48% |
| 38 | 688767.SH | 博拓生物 | 2023-09-25 | — | — | 体外诊断 | 37.49 | 33.03 | 54.58 | 2.39 | — | 55.99 | -75.04% | -82.82% | -20.76% | -23.91% |
| 39 | 688075.SH | 安旭生物 | 2023-09-25 | — | — | 体外诊断 | 38.5 | 25.44 | 40.48 | 0.95 | — | 48.93 | -52.60% | -48.57% | -19.34% | -7.42% |
免责声明：数据相关栏目所收集数据，均来自第三方个人或企业公开数据以及国家统计网站公开发布数据，数据由计算机技术自动收集更新再由作者校验，作者将尽力校验，但不能保证数据的完全准确。 阅读本栏目的用户必须明白，图表所示结果或标示仅供学习参考使用，均不构成交易依据。任何据此进行交易等行为，而引致的任何损害后果，本站概不负责。
关注微信公众号
获取更多数据
获取更多数据
关闭 X